Last reviewed · How we verify

NAC — Competitive Intelligence Brief

NAC (NAC) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Mucolytic agent and antioxidant. Area: Otology / Respiratory / General.

marketed Mucolytic agent and antioxidant Disulfide bonds in mucoproteins; glutathione synthesis pathway Otology / Respiratory / General Small molecule Live · refreshed every 30 min

Target snapshot

NAC (NAC) — Otologic Pharmaceutics, Inc.. NAC (N-acetylcysteine) is a mucolytic and antioxidant agent that breaks down mucus viscosity and replenishes intracellular glutathione to reduce oxidative stress.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
NAC TARGET NAC Otologic Pharmaceutics, Inc. marketed Mucolytic agent and antioxidant Disulfide bonds in mucoproteins; glutathione synthesis pathway

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Mucolytic agent and antioxidant class)

  1. Otologic Pharmaceutics, Inc. · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). NAC — Competitive Intelligence Brief. https://druglandscape.com/ci/nac. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators: